Virtual Reality With Mirror Therapy on Upper Limb Function
Launched by KAFRELSHEIKH UNIVERSITY · Dec 6, 2024
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how two different therapies—Virtual Reality (VR) and Mirror Therapy (MT)—can help improve the use of arms and hands in children with hemiplegic Cerebral Palsy (CP), a condition that affects movement on one side of the body. The study will include boys and girls aged 4 to 10 years. Children will be divided into three groups: one group will use VR along with regular physical therapy, another group will use Mirror Therapy with their physical therapy, and the last group will use both VR and Mirror Therapy together along with physical therapy.
To participate in this trial, children must have a diagnosis of spastic hemiplegic CP from a doctor and should be able to understand verbal instructions. They should also be at levels 1 or 2 in terms of their ability to move. However, children will not be included if they have serious physical deformities, problems with sight or hearing, or if they have had certain treatments like Botox in the last six months. This trial is not yet recruiting participants, but it aims to find out which of the three approaches is most effective in helping these children improve their upper limb function.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Children will be included in the study if they fulfil the following criteria:
- • 1. A medical diagnosis of spastic hemiplegic CP made by pediatric neurologists.
- • 2. Children with spasticity grades ranged from 1 to 1+ according to MAS.
- • 3. Their age range from 4 to 10 years.
- • 4. Children level 1 and level 2 in gross motor functional classification (GMFC 1\&2)
- Exclusion Criteria:
- * Children will be excluded from the study if:
- • 1. They had a permanent deformity (bony or soft tissue contractures).
- • 2. Children having visual or auditory defects.
- • 3. Children who can not understand verbal commands
- • 4. Children who had Botox application to the upper extremity in the past 6 months or had undergone a previous surgical intervention to wrist and hand.
About Kafrelsheikh University
Kafrelsheikh University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that contribute to the enhancement of healthcare practices and patient outcomes. With a strong emphasis on interdisciplinary collaboration, the university harnesses its diverse expertise in medical sciences, engineering, and technology to conduct rigorous clinical studies. Kafrelsheikh University aims to foster innovation in clinical research, ensuring compliance with ethical standards and regulatory requirements, while actively engaging in community health initiatives to address pressing health challenges. Through its commitment to excellence, the university seeks to develop evidence-based solutions that improve health and well-being at both local and global levels.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kafr Ash Shaykh, , Egypt
Patients applied
Trial Officials
Mohamed B Ibrahim, Ass.Prof.
Study Chair
head of pediatric department in faculty of physical therapy Kafrelshiekh university
Osama A El-Agamy, Professor
Study Director
Professor and head of department of pediatric department Faculty of medicine Kafrelshiekh university
Sara Y Abdel Elglil, Lecturer
Study Director
Lecturer in pediatric department in faculty of physical therapy Kafrelshiekh University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported